Article
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
British journal of haematology - 1 May 1996
Silla L M, Pincus S M, Locker J D, Glover J, Elder E M, Donnenberg A D, Nardi N B, Bryant J, Ball E D, Whiteside T L
Abstract excerpt
Activated natural killer (A-NK) cells, a subset of CD56(dim)CD3- lymphocytes, are obtained from PBMC of normal donors by adherence to plastic and culture in the presence of IL2. In this study we tested the feasibility of generating A-NK cells in patients with Ph+ chronic myeloid leukaemia (CML)....
Topics
- Antigens, CD
- Base Sequence
- Cell Division
- Cytotoxicity, Immunologic
- Fusion Proteins, bcr-abl
- Gene Rearrangement
- Humans
- Killer Cells, Lymphokine-Activated
- Killer Cells, Natural
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lymphocyte Activation
- Molecular Sequence Data
